Search

Your search keyword '"Lopez-Guerrero, JA"' showing total 20 results

Search Constraints

Start Over You searched for: Author "Lopez-Guerrero, JA" Remove constraint Author: "Lopez-Guerrero, JA" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
20 results on '"Lopez-Guerrero, JA"'

Search Results

1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

2. Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study

5. Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients

6. Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial.

7. USP1 Expression Driven by EWS::FLI1 Transcription Factor Stabilizes Survivin and Mitigates Replication Stress in Ewing Sarcoma.

8. EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis.

9. Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.

10. A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments.

11. Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study.

12. Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study.

13. A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors.

14. CUL4A , ERCC5 , and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study.

15. Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial.

16. CDKN2A germline alterations in melanoma patients with personal or familial history of pancreatic cancer.

17. PCA3 as a second-line biomarker in a prospective controlled randomized opportunistic prostate cancer screening programme.

18. High-risk gastrointestinal stromal tumour (GIST) and synovial sarcoma display similar angiogenic profiles: a nude mice xenograft study.

19. Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.

20. Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.

Catalog

Books, media, physical & digital resources